Document is current
Any future updates will be listed below
-
Authors
Whelton, Paul K. https://orcid.org/0000-0002-2225-383X
Picone, Dean S. https://orcid.org/0000-0002-4760-1634
Padwal, Raj https://orcid.org/0000-0003-3541-2817
Campbell, Norm R. C. https://orcid.org/0000-0002-1093-4742
Drawz, Paul
Rakotz, Michael K.
Parati, Gianfranco
Zhang, Xin-Hua
Sharman, James E. https://orcid.org/0000-0003-2792-0811
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (P20GM109036)
National Heart Foundation of Australia (104774)
- License Information
-
More Information
Article History
Received: 7 November 2021
Revised: 6 February 2022
Accepted: 23 February 2022
First Online: 12 March 2022
Competing interests
: None for PKW, PD, MKR, and XHZ. DSP and JES are consultants for HEARTS in the Americas, an initiative of the Pan American Health Organization. JES is principal investigator of a National Health and Medical Research Council partnership grant (S0026615) that includes a medical technology company that manufactures a central blood pressure monitor. RP is CEO of mmHg Inc., a digital health company and provider of BP telemonitoring software. NRCC reports personal fees from Resolve to Save Lives (RTSL), the Pan American Health Organization and the World Bank, unrelated to the current manuscript content; and serving as an unpaid consultant on dietary sodium and hypertension control for numerous governmental and nongovernmental organizations. GP reports honoraria for lectures supported by Omron HealthCare.
